W.R. Grace v. Elysium Health — Delaware Court Rejects Patent Unenforceability Defense After $3.6M Infringement Verdict
A Delaware federal judge found that supplement maker Elysium Health failed to prove inequitable conduct or unclean hands by W.R. Grace in connection with nicotinamide riboside patents — leaving intact a $3.6 million willful infringement verdict.